|
|
Article: DATATRAK Establishes New Product Offering Aimed at Expanding Business in Phase IV Clinical Trials; New Product Offering Branded as "DATATRAK Phase IV" Leverages Flexible Architecture Providing Customers with a "Menu" of Functionality.
- Article from:
- PR Newswire
- Article date:
- April 5, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DATATRAK International, Inc. , the leading and most experienced Application Service Provider ("ASP") in the Electronic Data Capture ("EDC") industry, today announced the expansion of its product offerings to include the availability of a customizable data collection platform that is specifically targeted towards opportunities represented by large Phase IV clinical trials, traditionally known as Post Marketing Surveillance (PMS) or Registry studies. Phase IV studies can contain 5,000 to 20,000 participants. It is anticipated that the proportion of Phase IV studies will increase in the future because of competitive marketing pressures on products that face patent ...
Related newspaper, magazine, and journal articles:
|
|
Article: DATATRAK International Receives Notification From ...
PR Newswire;
December 17, 2002 ;
700+ words
...DATATRAK International, Inc. today announced that ... Market would be accepted. DATATRAK International, Inc. is a worldwide ASP ... patients in 39 countries. DATATRAK International, Inc.'s product suite ...
|
|